Andy Mehrotra

Andy Mehrotra is an accomplished leader in the biopharmaceutical and technology sectors, currently serving as CEO of Unipr since January 2022, where a focus on optimizing research portfolios through integrated project ecosystems and artificial intelligence enhances R&D productivity. Prior to Unipr, Andy founded and led EightSpokes, a cloud-based Project Portfolio Management system aimed at accelerating drug and device development from May 2012 to December 2021. Earlier experience includes strategic roles at Sage Therapeutics, Sanofi, Abbott, Zero Corporation.Com Pty Ltd, and IMS Health, contributing to product commercialization, marketing strategies, and digital transformation. Educational credentials include master's degrees from both Massachusetts Institute of Technology and Harvard Medical School, an MBA from AGSM @ UNSW Business School, and a Bachelor of Pharmacy from Karnatak University.